These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7622763)

  • 1. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma.
    Dockhorn R; Vanden Burgt JA; Ekholm BP; Donnell D; Cullen MT
    J Allergy Clin Immunol; 1995 Jul; 96(1):50-6. PubMed ID: 7622763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma.
    Kleerup EC; Tashkin DP; Cline AC; Ekholm BP
    Chest; 1996 Mar; 109(3):702-7. PubMed ID: 8617079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
    Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
    Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
    Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
    Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
    Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparability of ventolin formulated with hydrofluoroalkane or conventional chlorofluorocarbon propellants in children with asthma.
    Shapiro G; Bronsky E; Murray A; Barnhart F; VanderMeer A; Reisner C
    Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1219-25. PubMed ID: 11115306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma.
    Nelson H; Kemp JP; Bieler S; Vaughan LM; Hill MR
    Chest; 1999 Feb; 115(2):329-35. PubMed ID: 10027428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
    Bronsky E; Ekholm BP; Klinger NM; Colice GL
    J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung delivery of salbutamol by dry powder inhaler (Turbuhaler) and small volume antistatic metal spacer (Airomir CFC-free MDI plus NebuChamber).
    Lipworth BJ; Clark DJ
    Eur Respir J; 1997 Aug; 10(8):1820-3. PubMed ID: 9272925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Spacehaler for delivery of salbutamol: a comparison with the standard metered-dose inhaler plus Volumatic spacer device.
    Gunawardena KA; Sohal T; Jones JI; Upchurch FC; Crompton GK
    Respir Med; 1997 May; 91(5):311-6. PubMed ID: 9176650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic concentrations of salbutamol and HFA-134a after inhalation of salbutamol sulfate in a chlorofluorocarbon-free system.
    Harrison LI; Cline A; Wells TM; Jacobson JP; Cooper KM; Chang SF; Nelson JR; Ekholm BP; Morganroth J
    Ther Drug Monit; 1996 Jun; 18(3):240-4. PubMed ID: 8738762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalence of salbutamol 200 microg four times daily propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Eastern European study group.
    Salat D; Popov D; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S22-8. PubMed ID: 10919682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study Group.
    Baumgarten CR; Dorow P; Weber HH; Gebhardt R; Kettner J; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S17-21. PubMed ID: 10919681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers.
    Hughes DA; Woodcock A; Walley T
    Thorax; 1999 Dec; 54(12):1087-92. PubMed ID: 10567628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
    Lumry W; Noveck R; Weinstein S; Barnhart F; Vandermeer A; Murray A; Reisner C
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.